 Erika Chelales
Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cellulose | 3 | 2021 | 58 | 0.890 |
Why?
| | Ethanol | 4 | 2021 | 627 | 0.770 |
Why?
| | Liver | 1 | 2021 | 1888 | 0.380 |
Why?
| | Catheter Ablation | 3 | 2021 | 353 | 0.380 |
Why?
| | Liver Neoplasms | 2 | 2021 | 783 | 0.210 |
Why?
| | Models, Animal | 2 | 2021 | 392 | 0.190 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2021 | 27 | 0.170 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2021 | 15 | 0.170 |
Why?
| | Acidosis | 1 | 2022 | 105 | 0.170 |
Why?
| | Rats, Inbred F344 | 1 | 2021 | 268 | 0.170 |
Why?
| | Necrosis | 1 | 2021 | 244 | 0.160 |
Why?
| | Central Nervous System Depressants | 1 | 2021 | 83 | 0.160 |
Why?
| | Thrombelastography | 1 | 2021 | 178 | 0.150 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2022 | 216 | 0.150 |
Why?
| | Accommodation, Ocular | 1 | 2019 | 15 | 0.150 |
Why?
| | Blood Coagulation | 1 | 2021 | 268 | 0.150 |
Why?
| | Drug Labeling | 1 | 2019 | 37 | 0.150 |
Why?
| | Presbyopia | 1 | 2019 | 15 | 0.140 |
Why?
| | Mass Media | 1 | 2019 | 41 | 0.140 |
Why?
| | Reading | 1 | 2019 | 136 | 0.130 |
Why?
| | Breast Neoplasms | 2 | 2021 | 2456 | 0.130 |
Why?
| | Vision Disorders | 1 | 2019 | 178 | 0.130 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2019 | 372 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 1141 | 0.100 |
Why?
| | Rats | 1 | 2021 | 5614 | 0.090 |
Why?
| | Mice, Inbred BALB C | 2 | 2022 | 1253 | 0.070 |
Why?
| | Animals | 5 | 2022 | 38109 | 0.070 |
Why?
| | Swine | 2 | 2021 | 833 | 0.070 |
Why?
| | Cyclophosphamide | 1 | 2022 | 266 | 0.040 |
Why?
| | Fluorescein | 1 | 2021 | 24 | 0.040 |
Why?
| | Needles | 1 | 2021 | 62 | 0.040 |
Why?
| | Female | 4 | 2021 | 78376 | 0.040 |
Why?
| | Injections | 1 | 2021 | 197 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2022 | 389 | 0.040 |
Why?
| | Pupil | 1 | 2019 | 22 | 0.040 |
Why?
| | Mice, Nude | 1 | 2021 | 688 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 919 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 735 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2021 | 930 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2021 | 395 | 0.030 |
Why?
| | Male | 2 | 2021 | 72406 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 1095 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2020 | 1465 | 0.030 |
Why?
| | Visual Acuity | 1 | 2019 | 489 | 0.030 |
Why?
| | Anticoagulants | 1 | 2021 | 724 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2022 | 3550 | 0.030 |
Why?
| | Mice | 2 | 2022 | 18365 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2499 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3415 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2430 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2022 | 5997 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2021 | 2738 | 0.020 |
Why?
| | Humans | 5 | 2022 | 144957 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3676 | 0.020 |
Why?
| | Middle Aged | 1 | 2019 | 35928 | 0.010 |
Why?
| | Adult | 1 | 2019 | 40506 | 0.010 |
Why?
|
|
Chelales's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|